C12Y 402/99018
Dna-lyase
Official title: DNA-(apurinic or apyrimidinic site)lyase (4.2.99.18)
C12Y402/99018 (Dna-lyase) appears on 15 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 25
- Assignees
- 15
- Inventors
- 54
- Latest grant
- 24 Mar 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 4 |
| 2017 | 3 | 2 |
| 2018 | 3 | 4 |
| 2019 | 2 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 3 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- NEIL3 peptides and vaccines including the same24 Mar 2020US 10,597,431 B2Oncotherapy Science, Inc.
- Pharmaceutical composition for inhibition of cancer cell metastasis including siRNA for ribosomal protein S316 Jul 2019US 10,351,855 B2
- Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer12 Mar 2019US 10,227,659 B2Dignity Health
- Method for performing multiple enzyme reactions in a single tube18 Dec 2018US 10,155,939 B1New England Biolabs, Inc.
- Compositions comprising a Sirt6 activator as a component of a yeast ferment extract and a DNA repair enzyme17 Jul 2018US 10,022,314 B2ELC Management LLC
- Method and kit for regenerating reusable initiators for nucleic acid synthesis9 Apr 2026US 2026/0098287 A1Cheng-Yao Chen
- Full light repair5 Dec 2024US 2024/0398885 A1Coty Inc.
- Neil2 protein therapy for treatment of viral infection9 Nov 2023US 2023/0355725 A1Board of Regents, The University of Texas System
- Nucleobase Editors16 Feb 2023US 2023/0051661 A1Agency for Science, Technology and Research
- Methods for the treatment of trinucleotide repeat exapnsion disorders associated with ogg1 activity9 Feb 2023US 2023/0041178 A1Triplet Therapeutics, Inc.
Most cited
By later US patents
- Chimeric proteins for detection and quantitation of DNA mutations, DNA sequence variations, DNA damage and DNA mismatches100US 6,365,355 B1The Regents of the University of California · 2002
- Method for performing multiple enzyme reactions in a single tube24US 10,155,939 B1New England Biolabs, Inc. · 2018
- Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity2US 9,624,235 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2017
- Treatment of disease conditions via administration of DNA repair enzyme1US 8,865,160 B2University of South Alabama · 2014
- Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer1US 9,637,798 B2Dignity Health · 2017